A

AbCellera Biologics
D

ABCL

1.97500
USD
-0.02
(-0.75%)
مغلق
حجم التداول
39,536
الربح لكل سهم
-1
العائد الربحي
-
P/E
-4
حجم السوق
589,507,211
أصول ذات صلة
AMAT
AMAT
-3.340
(-2.08%)
157.560 USD
AMD
AMD
-0.805
(-0.72%)
110.325 USD
AVGO
AVGO
-0.680
(-0.30%)
228.770 USD
INTC
INTC
-0.540
(-2.62%)
20.060 USD
MRVL
MRVL
-1.270
(-2.05%)
60.690 USD
MU
MU
-1.750
(-1.84%)
93.380 USD
NVDA
NVDA
-1.600
(-1.20%)
131.300 USD
QCOM
QCOM
-2.250
(-1.52%)
145.330 USD
SWKS
SWKS
-0.930
(-1.32%)
69.390 USD
TSM
TSM
-3.370
(-1.72%)
192.030 USD
المزيد
الأخبار المقالات

العنوان: AbCellera Biologics

القطاع: Healthcare
الصناعة: Biotechnology
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to theclinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.